NCT03876275

Brief Summary

Extended arthrodesis of the spine is indicated in the treatment of deformities. The principle of the intervention is to correct the spinal imbalance and to obtain a fusion of the vertebral segment operated in order to guarantee the durability of this correction, in order to guarantee a functional result the best possible one. There is a great disparity in the techniques available to obtain this result: as regards the correction of the deformation itself, it is possible to resort to various types of gestures aimed at "freeing" the spine to allow the getting the correction. It may be staged or transpedicular osteotomies or previous releases (staged discectomies). Regarding the arthrodesis itself, this can be obtained by an isolated posterior graft or by a circumferential graft itself performed in a time using interbody cages PLIF type (posterior lumbar interbody fusion) or TLIF (transforaminal interbody fusion) or in two stages by a complementary anterior graft. These are heavy interventions with a high complication rate. The choice of this or that technique is based on data from the literature and remains at the discretion of the surgeon who makes the surgical indication. However, it has never been possible to compare these different techniques in a prospective study. The few articles comparing the different techniques tend to show that there is no significant difference between the techniques with a higher complication rate for the two-step techniques. However, these are retrospective studies, with all the biases that this implies and despite these results the disparity in surgical indications remains substantial. The objective of this work is therefore to evaluate, according to an identical protocol, the different surgical techniques for the treatment of spinal deformities associated with a fusion in order to determine the morbidity associated with each of the techniques and if this morbidity is justified by a better functional result at a minimum follow-up of two years.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
193

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2019

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

March 7, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 15, 2019

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 3, 2021

Completed
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 11, 2023

Completed
Last Updated

September 13, 2023

Status Verified

September 1, 2023

Enrollment Period

2 years

First QC Date

March 7, 2019

Last Update Submit

September 11, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Surgical revision rate

    Surgical revision rate following double-approach techniques and single posterior approach techniques

    year 2

Secondary Outcomes (11)

  • duration of the procedure

    Day 1

  • bleeding during the procedure

    Day 1

  • quality of life questionnary Oswestry v2

    Day 0

  • quality of life questionnary SF-12

    Day 0

  • Visual Analog Score for pain

    Day 0

  • +6 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing arthrodesis including the sacrum and extending to T11 or greater

You may qualify if:

  • Patient whose age ≥ 18 years
  • Patient operated on an arthrodesis including the sacrum and extending to T11 or greater
  • Francophone patient
  • Patient not opposing his participation in the research protocol

You may not qualify if:

  • Patient under tutorship or curatorship
  • Patient deprived of liberty

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Groupe Hospitalier Paris Saint-Joseph

Paris, 75014, France

Location

Study Officials

  • Guillaume RIOUALLON, MD

    Fondation Hôpital Saint-Joseph

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 7, 2019

First Posted

March 15, 2019

Study Start

March 1, 2019

Primary Completion

March 3, 2021

Study Completion

September 11, 2023

Last Updated

September 13, 2023

Record last verified: 2023-09

Locations